Stage IVA Major Salivary Gland Cancer AJCC v7
5 clinical trials · Condition
◉ Watch Stage IVA Major Salivary Gland Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma (NCT01604772) | National Cancer Institute (NCI) | 2012-07-23 |
| Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" (NCT01365169) | M.D. Anderson Cancer Center | 2011-05-25 |
| Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617) | National Cancer Institute (NCI) | 2011-02-10 |
| Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (NCT01175980) | National Cancer Institute (NCI) | 2010-08-06 |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT00588770) | National Cancer Institute (NCI) | 2008-08-08 |
Track Stage IVA Major Salivary Gland Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.